Literature DB >> 19299708

4-1BB functions as a survival factor in dendritic cells.

Beom K Choi1, Young H Kim, Patrick M Kwon, Sang C Lee, Sang W Kang, Moon S Kim, Myoung J Lee, Byoung S Kwon.   

Abstract

4-1BB (CD137) is expressed on dendritic cells (DCs) and its biological function has remained largely unresolved. By comparing 4-1BB-intact (4-1BB(+/+)) and 4-1BB-deficient (4-1BB(-/-)) DCs, we found that 4-1BB was strongly induced on DCs during the maturation and that DC maturation was normal in the absence of 4-1BB. However, DC survival rate was low in the absence of 4-1BB, which was due to the decreased Bcl-2 and Bcl-x(L) in 4-1BB(-/-) DCs compared with 4-1BB(+/+) DCs after DC maturation. Consistent with these results, 4-1BB(-/-) DCs showed an increased turnover rate in steady state and more severely decreased in spleen by injecting LPS compared with 4-1BB(+/+) DCs. When OVA-pulsed DCs were adoptively transferred to recipient mice along with OVA-specific CD4(+) T cells, 4-1BB(-/-) DCs did not properly migrate to the T cell zone in lymph nodes and poorly induced proliferation of CD4(+) T cells, although both DCs comparably expressed functional CCR7. Eventually, 4-1BB(-/-) DCs generated a reduced number of OVA-specific memory CD4(+) T cells compared with 4-1BB(+/+) DCs. To further assess the role of 4-1BB on DC longevity in vivo, 4-1BB(+/+) and 4-1BB(-/-) C57BL/6 were administrated with Propionibacterium acnes that develop liver granuloma by recruiting DCs. Number and size of granuloma were reduced in the absence of 4-1BB, but the inflammatory cytokine level was comparable between the mice, which implied that the granuloma might be reduced due to the decreased longevity of DCs. These results demonstrate that 4-1BB on DCs controls the duration, DC-T interaction, and, therefore, immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299708      PMCID: PMC2681223          DOI: 10.4049/jimmunol.0800459

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Modulation of the immune response through 4-1BB.

Authors:  G Sica; L Chen
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

2.  Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity.

Authors:  Min Chen; Li Huang; Jin Wang
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

3.  The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells.

Authors:  K M Ardeshna; A R Pizzey; S Devereux; A Khwaja
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

4.  Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.

Authors:  H R Salih; S G Kosowski; V F Haluska; G C Starling; D T Loo; F Lee; A A Aruffo; P A Trail; P A Kiener
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

5.  NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.

Authors:  I Melero; J V Johnston; W W Shufford; R S Mittler; L Chen
Journal:  Cell Immunol       Date:  1998-12-15       Impact factor: 4.868

6.  Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells.

Authors:  Seung-Woo Lee; Yunji Park; Takanori So; Byoung S Kwon; Hilde Cheroutre; Robert S Mittler; Michael Croft
Journal:  Nat Immunol       Date:  2008-07-06       Impact factor: 25.606

7.  CD4 T cells integrate signals delivered during successive DC encounters in vivo.

Authors:  Susanna Celli; Zacarias Garcia; Philippe Bousso
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

8.  Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation.

Authors:  M D Denton; C S Geehan; S I Alexander; M H Sayegh; D M Briscoe
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

9.  Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization.

Authors:  M D Gunn; S Kyuwa; C Tam; T Kakiuchi; A Matsuzawa; L T Williams; H Nakano
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

10.  Dendritic cell survival and maturation are regulated by different signaling pathways.

Authors:  M Rescigno; M Martino; C L Sutherland; M R Gold; P Ricciardi-Castagnoli
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

View more
  29 in total

1.  Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation.

Authors:  Hye J Kim; Jong S Lee; Jung D Kim; Hee J Cha; Ahra Kim; Sun K Lee; Sang C Lee; Byoung S Kwon; Robert S Mittler; Hong R Cho; Byungsuk Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  4-1BB protects dendritic cells from prostate cancer-induced apoptosis.

Authors:  Kuang Youlin; Zhang Jianwei; Gou Xin; Zhang Li; Weng Xiaodong; Liu Xiuheng; Zhu Hengchen; Chen Zhiyuan
Journal:  Pathol Oncol Res       Date:  2012-10-16       Impact factor: 3.201

3.  SA-4-1BBL and monophosphoryl lipid A constitute an efficacious combination adjuvant for cancer vaccines.

Authors:  Abhishek K Srivastava; Gunes Dinc; Rajesh K Sharma; Esma S Yolcu; Hong Zhao; Haval Shirwan
Journal:  Cancer Res       Date:  2014-09-24       Impact factor: 12.701

4.  Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12.

Authors:  José I Quetglas; Juan Dubrot; Jaione Bezunartea; Miguel F Sanmamed; Sandra Hervas-Stubbs; Cristian Smerdou; Ignacio Melero
Journal:  Mol Ther       Date:  2012-06-26       Impact factor: 11.454

Review 5.  Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy.

Authors:  Adam J Adler; Payal Mittal; Joseph M Ryan; Beiyan Zhou; Jeffrey S Wasser; Anthony T Vella
Journal:  Immunotherapy       Date:  2017-01       Impact factor: 4.196

6.  Immune regulation through mitochondrion-dependent dendritic cell death induced by T regulatory cells.

Authors:  Min Chen; Kumar Felix; Jin Wang
Journal:  J Immunol       Date:  2011-10-26       Impact factor: 5.422

Review 7.  SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines.

Authors:  Rajesh K Sharma; Esma S Yolcu; Haval Shirwan
Journal:  Expert Rev Vaccines       Date:  2014-03       Impact factor: 5.217

8.  CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.

Authors:  Matthew W Anderson; Shuchun Zhao; Aharon G Freud; Debra K Czerwinski; Holbrook Kohrt; Ash A Alizadeh; Roch Houot; Denize Azambuja; Irene Biasoli; José Carlos Morais; Nelson Spector; Hernan F Molina-Kirsch; Roger A Warnke; Ronald Levy; Yasodha Natkunam
Journal:  Am J Pathol       Date:  2012-09       Impact factor: 4.307

9.  Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice.

Authors:  Gloria H Y Lin; Yuanqing Liu; Thanuja Ambagala; Byoung S Kwon; Pamela S Ohashi; Tania H Watts
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

10.  Idd9.2 and Idd9.3 protective alleles function in CD4+ T-cells and nonlymphoid cells to prevent expansion of pathogenic islet-specific CD8+ T-cells.

Authors:  Emma E Hamilton-Williams; S B Justin Wong; Xavier Martinez; Daniel B Rainbow; Kara M Hunter; Linda S Wicker; Linda A Sherman
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.